Hong Kong · Delayed Price · Currency is HKD Zai Lab Statistics
Total Valuation
Zai Lab has a market cap or net worth of HKD 23.52 billion. The enterprise value is 20.67 billion.
| Market Cap | 23.52B |
| Enterprise Value | 20.67B |
Important Dates
The last earnings date was Thursday, August 6, 2026.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 1.12B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +6.01% |
| Shares Change (QoQ) | +0.87% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 91.37M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.67 |
| PB Ratio | 4.94 |
| P/TBV Ratio | 5.79 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.86 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.13, with a Debt / Equity ratio of 0.42.
| Current Ratio | 2.13 |
| Quick Ratio | 1.61 |
| Debt / Equity | 0.42 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.82 |
| Interest Coverage | -44.13 |
Financial Efficiency
Return on equity (ROE) is -26.91% and return on invested capital (ROIC) is -17.90%.
| Return on Equity (ROE) | -26.91% |
| Return on Assets (ROA) | -14.75% |
| Return on Invested Capital (ROIC) | -17.90% |
| Return on Capital Employed (ROCE) | -40.87% |
| Weighted Average Cost of Capital (WACC) | 8.02% |
| Revenue Per Employee | 1.98M |
| Profits Per Employee | -827,346 |
| Employee Count | 1,784 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 5.67 |
Taxes
| Income Tax | -19.68M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -26.23% in the last 52 weeks. The beta is 0.78, so Zai Lab's price volatility has been lower than the market average.
| Beta (5Y) | 0.78 |
| 52-Week Price Change | -26.23% |
| 50-Day Moving Average | 15.67 |
| 200-Day Moving Average | 15.38 |
| Relative Strength Index (RSI) | 73.64 |
| Average Volume (20 Days) | 11,111,838 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 6.62 |
Income Statement
In the last 12 months, Zai Lab had revenue of HKD 3.53 billion and -1.48 billion in losses. Loss per share was -13.32.
| Revenue | 3.53B |
| Gross Profit | 133.20M |
| Operating Income | -2.07B |
| Pretax Income | -1.50B |
| Net Income | -1.48B |
| EBITDA | -1.95B |
| EBIT | -2.07B |
| Loss Per Share | -13.32 |
Balance Sheet
The company has 4.84 billion in cash and 2.00 billion in debt, with a net cash position of 2.85 billion.
| Cash & Cash Equivalents | 4.84B |
| Total Debt | 2.00B |
| Net Cash | 2.85B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 4.76B |
| Book Value Per Share | 42.41 |
| Working Capital | 3.81B |
Cash Flow
In the last 12 months, operating cash flow was -1.05 billion and capital expenditures -48.51 million, giving a free cash flow of -1.09 billion.
| Operating Cash Flow | -1.05B |
| Capital Expenditures | -48.51M |
| Depreciation & Amortization | 124.97M |
| Net Borrowing | 418.70M |
| Free Cash Flow | -1.09B |
| FCF Per Share | n/a |
Margins
Gross margin is 3.78%, with operating and profit margins of -58.74% and -41.86%.
| Gross Margin | 3.78% |
| Operating Margin | -58.74% |
| Pretax Margin | -42.42% |
| Profit Margin | -41.86% |
| EBITDA Margin | -55.20% |
| EBIT Margin | -58.74% |
| FCF Margin | n/a |
Dividends & Yields
Zai Lab does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.01% |
| Shareholder Yield | -6.01% |
| Earnings Yield | -6.28% |
| FCF Yield | -4.65% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for Zai Lab is 21.19, which is 1.50% higher than the current price. The consensus rating is "Buy".
| Price Target | 21.19 |
| Price Target Difference | 1.50% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (3Y) | 16.04% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on March 30, 2022. It was a forward split with a ratio of 10.
| Last Split Date | Mar 30, 2022 |
| Split Type | Forward |
| Split Ratio | 10 |
Scores
Zai Lab has an Altman Z-Score of 0.04 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.04 |
| Piotroski F-Score | 2 |